Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. by Kazlauskaite, J, Sanghera, N, Sylvester, I, Vénien-Bryan, C, Pinheiro, T

Neuroprotective Activities of <i>Boophone haemanthoides</i> (Amaryllidaceae) Extract and Its Chemical Constituents by Abobaker S. Ibrakaw, Sylvester I. Omoruyi, Okobi E. Ekpo, Ahmed A. Hussein

Get full text

4-Oxatricyclo[5.2.1.0^2,6]dec-8-ene-3,5-dione Derivatives as NMDA Receptor- and VGCC Blockers with Neuroprotective Potential by Ayodeji O. Egunlusi, Sarel F. Malan, Sylvester I. Omoruyi, Okobi E. Ekpo, Jacques Joubert

Get full text

Characterization and Toxicity of Hypoxoside Capped Silver Nanoparticles by Umar M. Badeggi, Sylvester I. Omoruyi, Enas Ismail, Charlene Africa, Subelia Botha, Ahmed A. Hussein

Get full text

Neuroprotective Activities of <i>Crossyne flava</i> Bulbs and Amaryllidaceae Alkaloids: Implications for Parkinson’s Disease by Sylvester I. Omoruyi, Abobaker S. Ibrakaw, Okobi E. Ekpo, James S. Boatwright, Christopher N. Cupido, Ahmed A. Hussein

Get full text

Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer’s disease agents by Sheunopa C. Mzezewa, Sylvester I. Omoruyi, Luke S. Zondagh, Sarel F. Malan, Okobi E. Ekpo, Jacques Joubert

Get full text

Characterization of 2'-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. by Rhie, A, Kirby, L, Sayer, N, Wellesley, R, Disterer, P, Sylvester, I, Gill, A, Hope, J, James, W, Tahiri-Alaoui, A